Fact is, they are receiving substantial funding here and there has been no negative announcements since the FDA approval of Febridx.
This stock simply requires a rerate. It is just absurd to think otherwise.
- Forums
- ASX - By Stock
- Ann: Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study
LDX
lumos diagnostics holdings limited
Add to My Watchlist
7.41%
!
2.9¢

Fact is, they are receiving substantial funding here and there...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $21.70M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $44.36K | 1.538M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 104764 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 324100 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 104764 | 0.029 |
5 | 468600 | 0.028 |
3 | 218288 | 0.027 |
3 | 581461 | 0.026 |
7 | 641153 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 324100 | 5 |
0.031 | 252105 | 5 |
0.032 | 51725 | 1 |
0.035 | 88000 | 1 |
0.037 | 493186 | 2 |
Last trade - 14.13pm 18/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online